Chemical Pathways of Peptide Degradation. VII. Solid State Chemical Instability of an Aspartyl Residue in a Model Hexapeptide

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Pharmaceutical Research

• Publication date

  1994-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1023/A:1018998312503PMID 7937533
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Degradation of aspartic acid and asparagine residues in human growth hormone-releasing factor.

  2009cited by this paper
• Degradation of growth hormone releasing factor analogs in neutral aqueous solution is related to deamidation of asparagine residues. Replacement of asparagine residues by serine stabilizes.

  2009cited by this paper
• Chemical Pathways of Peptide Degradation. IV. Pathways, Kinetics, and Mechanism of Degradation of an Aspartyl Residue in a Model Hexapeptide

  2004cited by this paper
• Pharmaceutics of protein drugs.

  1992cited by this paper
• The Effects of Formulation Variables on the Stability of Freeze-Dried Human Growth Hormone

  1991cited by this paper
• Formation of isoaspartate 99 in bovine and porcine somatotropins

  1990cited by this paper
• The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state

  1990cited by this paper
• Chemical Pathways of Peptide Degradation. II. Kinetics of Deamidation of an Asparaginyl Residue in a Model Hexapeptide

  1990cited by this paper
• Chemical Pathways of Peptide Degradation. III. Effect of Primary Sequence on the Pathways of Deamidation of Asparaginyl Residues in Hexapeptides

  1990cited by this paper
• Formation of isoaspartate at two distinct sites during in vitro aging of human growth hormone.

  1989cited by this paper
• Overview of the stability and handling of recombinant protein drugs.

  1989cited by this paper
• An Unexpected pH Effect on the Stability of Moexipril Lyophilized Powder

  1989cited by this paper
• Kinetics of the Aspartyl Transpeptidation of Daptomycin, a Novel Lipopeptide Antibiotic

  1989cited by this paper
• Stability of recombinant human epidermal growth factor in various solutions.

  1989cited by this paper
• Water Science Reviews 3: Water as a plasticizer: physico-chemical aspects of low-moisture polymeric systems

  1988cited by this paper
• The stability of cyclophosphamide in lyophilized cakes. Part I. Mannitol, lactose, and sodium bicarbonate as excipients.

  1988cited by this paper
• Non-equilibrium behavior of small carbohydrate-water systems

  1988cited by this paper
• Thermomechanical properties of small-carbohydrate–water glasses and ‘rubbers’. Kinetically metastable systems at sub-zero temperatures

  1988cited by this paper
• Effect of Moisture on the Stability of Solid Dosage Forms

  1988cited by this paper
• Peptides and related drugs: a review of their absorption, metabolism, and excretion.

  1986cited by this paper
• Study of freeze-drying in drug-additive binary system

  1986cited by this paper
• Mechanical Activation of Pharmaceutical Systems

  1985cited by this paper
• Isolation and characterization of 101-beta-lysozyme that possesses the beta-aspartyl sequence at aspartic acid-101.

  1985cited by this paper
• Stability of Parenterals

  1984cited by this paper
• Thermal decomposition of amorphous beta-lactam antibacterials.

  1977cited by this paper
• Thermal Decomposition of Amorphous β-Lactam Antibacterials

  1977cited by this paper
• Stability of solids and solid dosage forms.

  1974cited by this paper
• Water:A Comprehensive Treatise

  1972cited by this paper

• Accelerated storage for shelf-life prediction of lyophiles: temperature dependence of degradation of amorphous small molecular weight drugs and proteins.

  2023cites this paper
• Microenvironmental pH Modification in Buccal/Sublingual Dosage Forms for Systemic Drug Delivery

  2023cites this paper
• Development and validation of a stability indicating HPLC-DAD method for the determination of the peptide stigmurin

  2020cites this paper
• Formulation Composition and Process Affect Counterion for CSP7 Peptide

  2019cites this paper
• An Automated and Qualified Platform Method for Site-Specific Succinimide and Deamidation Quantitation Using Low-pH Peptide Mapping.

  2019cites this paper
• Characterization and quantification of succinimide using peptide mapping under low-pH conditions and hydrophobic interaction chromatography.

  2019cites this paper
• Effect of Water on the Chemical Stability of Amorphous Pharmaceuticals: 2. Deamidation of Peptides and Proteins.

  2018cites this paper
• Formulation for a novel inhaled peptide therapeutic for idiopathic pulmonary fibrosis

  2018cites this paper
• Building parity between brand and generic peptide products: Regulatory and scientific considerations for quality of synthetic peptides.

  2017cites this paper
• Citropin 1.1 Trifluoroacetate to Chloride Counter-Ion Exchange in HCl-Saturated Organic Solutions: An Alternative Approach

  2017cites this paper
• The stabilization of biopharmaceuticals: current understanding and future perspectives

  2017cites this paper
• Identification of key volatiles responsible for aroma changes of egg white antioxidant peptides during storage by HS-SPME-GC-MS and sensory evaluation

  2017cites this paper
• Mass Spectrometry Based Mechanistic Insights into Formation of Tris Conjugates: Implications on Protein Biopharmaceutics

  2016cites this paper
• A Tribute to Ronald T. Borchardt--Teacher, Mentor, Scientist, Colleague, Leader, Friend, and Family Man.

  2016cites this paper
• Chemical degradation of proteins in the solid state with a focus on photochemical reactions.

  2015cites this paper
• Detection and quantitation of succinimide in intact protein via hydrazine trapping and chemical derivatization.

  2014cites this paper
• Structure-Based Prediction of Asparagine and Aspartate Degradation Sites in Antibody Variable Regions

  2014cites this paper
• Production and characterisation of potato patatin-galactose, galactooligosaccharides, and galactan conjugates of great potential as functional ingredients.

  2014cites this paper
• Characterization of glycated lysozyme with galactose, galactooligosaccharides and galactan: Effect of glycation on structural and functional properties of conjugates

  2013cites this paper
• Improving the physical stability of freeze-dried amorphous sugar matrices by compression at several hundreds MPa.

  2013cites this paper
• Understanding correlations between secondary relaxations and thermal behaviour of biologically relevant molecules

  2013cites this paper
• Comparison of the in vitro and in vivo stability of a succinimide intermediate observed on a therapeutic IgG1 molecule

  2013cites this paper
• Forced degradation studies: an essential tool for the formulation development of vaccines

  2013cites this paper
• Mass Spectrometric Distinction of In-Source and In-Solution Pyroglutamate and Succinimide in Proteins: A Case Study on rhG-CSF

  2013cites this paper
• Formulation, Drug Product, and Delivery: Considerations for Fc‐Fusion Proteins

  2013cites this paper
• Degradation kinetics of an aspartyl-tripeptide-derived diketopiperazine under forced conditions.

  2012cites this paper
• Chemical Pathways of Peptide and Protein Degradation

  2012cites this paper
• CE-MS Identification of Amino Acid Sequence Inversion as a New Degradation Pathway of an Aspartyl Model Tripeptide

  2012cites this paper
• Chemical modifications of peptides and their impact on food properties.

  2011cites this paper
• Protein Conformation and Reactivity in Amorphous Solids

  2010cites this paper
• Temperature effect on the non-volatile compounds of Maillard reaction products derived from xylose-soybean peptide system: further insights into thermal degradation and cross-linking.

  2010cites this paper
• Mechanisms of protein stabilization in the solid state.

  2009cites this paper
• Microenvironmental pH modulation in solid dosage forms.

  2007cites this paper
• Formulation considerations for proteins susceptible to asparagine deamidation and aspartate isomerization.

  2006cites this paper
• Stability of Therapeutic Peptides and Proteins

  2005cites this paper
• Effects of acidic N + 1 residues on asparagine deamidation rates in solution and in the solid state.

  2005cites this paper
• Effects of sucrose and mannitol on asparagine deamidation rates of model peptides in solution and in the solid state.

  2005cites this paper
• A molecular dynamics simulation of reactant mobility in an amorphous formulation of a peptide in poly(vinylpyrrolidone).

  2004cites this paper
• Modelling the hydrolysis of succinimide: formation of aspartate and reversible isomerization of aspartic acid via succinimide.

  2003cites this paper
• Formulation development of protein dosage forms.

  2002cites this paper
• Hydrolysis in Pharmaceutical Formulations

  2002cites this paper
• Development and Manufacture of Protein Pharmaceuticals

  2002cites this paper
• Effect of 'pH' on the rate of asparagine deamidation in polymeric formulations: 'pH'-rate profile.

  2001cites this paper
• Solid-state chemical stability of proteins and peptides.

  1999cites this paper
• FDA perspective on peptide formulation and stability issues.

  1998cites this paper
• Bond Cleavage Reactions in Solid Aqueous Carbohydrate Solutions

  1998cites this paper
• Solid-state stability of human insulin. II. Effect of water on reactive intermediate partitioning in lyophiles from pH 2-5 solutions: stabilization against covalent dimer formation.

  1997cites this paper
• Solid-State Stability of Human Insulin I. Mechanism and the Effect of Water on the Kinetics of Degradation in Lyophiles from pH 2–5 Solutions

  1996cites this paper
• Effects of reducing sugars on the chemical stability of human relaxin in the lyophilized state.

  1996cites this paper